LAUSR

CheckMate 078: Patient‐Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non‐Small Cell Lung Cancer (NSCLC): OA10

Sign Up to like & get
recommendations!
2 Published in 2018 at "Journal of Thoracic Oncology"

DOI: 10.1016/j.jtho.2018.10.020

Abstract: Conclusion: We interrogated the characteristics of ERBB2 exon 20 insertions in a large cohort from single ethnicity. It demonstrated the response heterogeneity to afatinib among different ERBB2 exon 20 insertion subtypes. It highlighted the importance… read more here.

Keywords: reported outcomes; checkmate 078; outcomes pros; 078 patient ... See more keywords